Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin- dependent diabetes mellitus patients with hypertension

Journal of Internal Medicine

Volumn 244, Issue 2, 1998, Pages 95-107

  Ostman J ^a   Asplund, K ^b   Bystedt, T ^a   Dahlof B ^c   Jern, S ^c   Kjellstrom T ^d   Lithell, H ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Umeå Regional Hospital   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d HELSINGBORG HOSPITAL   (Sweden)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C peptide; Cholesterol; Glycosylated haemoglobin (HbA(1c); Insulin; Oral glucose tolerance test; Triglycerides

Indexed keywords

ALBUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; LIPID; METOPROLOL; QUINAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A; HUMANS; HYPERTENSION; INSULIN; ISOQUINOLINES; LIPIDS; MALE; METOPROLOL; MIDDLE AGED; QUALITY OF LIFE; SWEDEN; TETRAHYDROISOQUINOLINES;

EID: 0031904383     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00319.x     Document Type: Article

References (57)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: The Framingham Study. JAMA 1979; 241: 2035-8.
2. Pyörälä K, Laakso M, Uusitypa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3: 465-524.
3. Lithell HOL. Effect of antihypertensive drugs on insulin, glucose and lipid metabolism. Diabetes Care 1991; 14: 203-9.
4. Stein PP. Black HR. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 1991: 14: 425-8.
5. Sawicki PT. Mühlhauser I, Baba T, Berger M. Do angiotensinconverting enzyme inhibitors represent progress in hypertension care in diabetes mellitus? Diabetologia 1990; 33: 121-4.
6. Berne C. Metabolic effects of ACE inhibitors. J Intern Med 1991; 229 (Suppl. 2): 119-25.
7. Sawicki PT. Berger M. Metabolic effects of antihypertensive treatment with beta-blockers. J Intern Med 1991: 229 (Suppl. 2): 97-9.
8. Jauch KW, Hartl W, Guenther B, Wicklmayr M, Rett K, Dietze G. Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1987; 17: 448-54.
9. Ferrière M, Lachkar H, Richard J-L, Bringer J, Orsetti A, Mirouze J. Captopril and insulin sensitivity. Ann Intern Med 1985; 102: 134-5.
10. Gans ROB, Bilo HJG, Nauta JJP. Popp-Snijders C. Heine RJ. Donker AJM. The effect of angiotensin-I converting enzyme inhibition on insulin action in healthy volunteers. Eur J Clin Invest 1991; 21: 527-33.
11. Torlone E. Rambotti AM, Perriello G, Botta G, Santeusanio F, Brunetti P, Bolli GB. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin In patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension. Diabetologia 1991; 34: 119-25.
12. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868-73.
13. Rett K, Wicklmayr M, Dietze GJ. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas. biguanides and captopril (Letter). N Engl J Med 1988; 319: 1609.
14. Arauz-Pacheco C. Ramirez LC, Rios JM, Raskin P. Hypogiycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin dependent diabetes receiving sulfonyiurea therapy. Am J Med 1990: 89: 811-3.
15. De Mattia G, Laurenti Ö,Tullo G, Ziantoni R, Ferri C, Ventura C et al.. Captopril does not alter metabolic control in elderly hypertensive diabetics during secondary failure. J Hypertension 1988; 6 (Suppl. 1 ): 113-5.
16. Corcoran JS. Perkins JE, Hoffbrand BI, Yudkin JS. Treating hypertension in non-insulin-dependent diabetes: a comparison of atenolol. nifedipine. and captopril combined with bendrofluazide. Diab Med 1987; 4: 164-8.
17. Moore MP, Elliott TW, Nicholls MG. Hormonal and metabolic effects of enalapril treatment in hypertensive inhibitor NIDDM. Diab Care 1988; 11: 397-401.
18. Ueda Y, Aoi W, Yamachifka S. Shikaya T. Beneficial effects of angiotensin converting enzyme inhibitor on renal function and glucose homeoslasis in diabetics with hypertension. Nephron 1990: 55 (Suppl. 1): 85-9.
19. Prince MJ, Stuart CA. Padia M, Bandi Z, Holland B. Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient. Arch Intern Med 1988; 148: 2363-8.
20. Whitcroft IA, Thomas JM, Rawsthorne A, Wilkinson N, Thompson H. Effects of alpha and beta adrenoceptor blocking drugs and ACE inhibitors on long-term glucose and lipid control in hypertensive non-insulin-dependent diabetics. Horm Metab Res 1990; 22 (Suppl. 2): 42-6.
21. Holm G Johansson S, Vedin A, Wilhelmsson C, Smith II. The effect of beta-blockade on glucose tolerance and insulin release in adult diabetes. Acta Med Scand 1980; 208: 187-91.
22. Groop L, Tötterman K-J, Harno K, Gordin A. Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Acta Med Scand 1982; 211:7-12.
23. Micossi P, Pollavini G, Raggi U, Librenti MC, Garimberti B, Beggi P. Effects of metoprolol and propranolol on glucose tolerance and insulin secretion in diabetes mellitus. Harm Metabol Res 1984; 16: 59-63.
24. Ekberg G, Hansson B-G. Glucose tolerance and insulin release in hypertensive patients treated with the cardioselective beta-receptor blocking agent metoprolol. Acta Med Scand 1977; 202: 393-7.
25. Wright AD, Barber SG, Kendall MJ, Poole PH. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellilus. Br Med J 1979; 1: 159-61.
26. Fagerberg B, Berglund A, Holme E, Wilheimsen L, Elmfeldt D. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol. J Int Med 1990; 227: 37-43.
27. Capewell S, Collier A, Matthews D, Hajducka C, Collier R, Clarke BF et al. A trial of the calcium antagonist felodipine in hypertensive Type 2 diabetic patients. Diab Med 1989: 6: 809-12.
28. Friedewald WT, Levy RI, Fredrickson DS. Estimation of plasma low density lipoprotein cholesterol concentration; without Use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
29. Jern S. Assessment of psychic side-effects of antihypertensive drugs. Acta Med Scand 1985; 693 (Suppl. 1): 103-6.
30. Jern S. Questionnaire for the assessment of symptoms and psychological effects in cardiovascular therapy (the ASPECT scale). Scand J Prim Health Care 1990; Supplement 1: 31-2.
31. United Kingdom Prospective Diabetes Study (UKPDS) 13: Relative efficacy of randomly allocated diet, sulphonylurea. insulin or metformin In patients with newly diagnosed non-insulin-dependent diabetes followed for three years. BMJ 1995;310:83-8.
32. Bak JF Gerdes LU, Schwartz-Sörensen N, Pedersen O. Effects of perindopril on insulin sensitivity and plasma lipid profile in hypertensive non-insulin-dependent diabetic patients. Am J Med 1992; 92: 69-72.
33. Jandrain B, Herbaut C, Depoorter J-C, Voorde K. Long-term (1-year) acceptability of perindopril in Type II diabetic patients with hypertension. Am J Med 1992; 92: 91-4.
34. Kawai K, Suzuki S, Murayama Y, Watanabe Y, Yamashita K. Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension. Diab Res Clin Pract 1992; 16: 137-43.
35. Torlone E, Britta M, Rambotti AM, Perriello G, Santeusanio F Brunetti P et al. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and Type II diabetes. Diabetes Care 1993; 16: 1347-55.
36. Vuorinen-Markkola H, Yki-Järvinen H. Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus. Metabolism 1995; 44: 85-9.
37. Suzuki M, Ikebuchi M, Yokota C, Shinozaki K, Harano Y. Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment. Clin Exp Hypertension 1995; 17: 1257-68.
38. Schiffrin EL, Deng LY, Larochell P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiontensin I-converting enzyme inhibitor. Comparison with effects of a β-blocker. Am J Hypertens 1995; 8: 129-36.
39. Julius S. Coronary disease in hypertension: a new mosaic. J Hypertens 1997; 15 (Suppl. 2): S3-S10.
40. Haffner SM. Lipoprotein (a) and diabetes. An update. Diab Care 1993; 16: 835-40.
41. Stornello M, Valvo EV, Scapellato L. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria. Nephron 1991; 58: 52-7.
42. Lacourcière Y, Nadeau A, Pirier L, Tandrède G. Captoril or conventional therapy in hypertensive Type II diabetics. Three-year analysis. Hypertension 1993; 21: 786-94.
43. Sano T, Kawamura T, Matsumae H, Sasaki H, Nakayama M. Hara T et al. Effects of long-term enalapril treatment on persistent microalbuminuria in well-controlled hypertensive and normotensive NIDDM patients. Diab Care 1994; 17: 420-4.
44. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P. Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. Br Med J 1988; 297: 1092-5.
45. Stornello M, Valvo EV, Scapellato L. Persistent albuminuria in normotensive non-insulin-dependent (type II) diabetic patients: comparative effects of angiotensin-converting enzyme inhibitors and b-adrenoceptor blockers. Clin Sci 1992; 82: 19-23.
46. Ravid M, Savin H, Jutrin I. Bental T. Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive Type II diabetic patients. Ann Int Med 1993; 118:577-81.
47. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WE Effect of anti-hypertensive therapy on the kidney in patients with diabetes: a meta regression analysis. Ann Int Med 1993; 118: 129-39.
48. Schmitz A, Hansen HH, Christensen T. Kidney function in newly-diagnosed Type 2 (non-insulin-dependent) diabetic patients, before and during treatment. Diabetologia 1989; 32: 434-9.
49. Wainai H, Katsukawa F, Takei I, Maruyama H, Kataoka K, Saruta T. Influence of glycemic control and hypertension on urinary microprotein excretion in non-insulin-dependent diabetes mellitus. J Diab Compl 1991; 3: 160-1.
50. UK Prospective Diabetes Study Group (UKPDS). IX. Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of Type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 1993; 36: 835-2.
51. Vora JP, Dolben J, Williams JD, Peters JR, Owens DR. Impact of initial treatment on renal function in newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 734-40.
52. Croog SH, Levine S. Testa MA et al The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
53. Fletcher A, Bulpitt CJ, Hawkins CM, Havinga TK, Ten Berge BS, May JF et al. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens 1990; 8:463-6.
54. Croog SH, Kong W. Levine S, Weir MR, Baume RM, Saunders E. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Arch Intern Med 1990; 150: 1733-41.
55. Herrick AL, Waller PC, Berkin KE, Pringle SD, Callender JS, Robertson MP et al. Comparison of enalapril and atenolol in mild - to - moderate hypertension. Am J Med 1989; 86: 421-6.
56. Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril. enalapril and propranolol. J Hum Hypertens 1990; 4: 217-25.
57. Os I. Bratland B. Dahlöf B, Gisholt K, Syvertsen J-O. Tretli S. Lisinopril or nifendipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. J Hypertens 1991: 9: 1097-104.